Cargando…

Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy

Cancer vaccines are promising treatments to prevent relapse after chemotherapy in acute myeloid leukemia (AML) patients, particularly for those who cannot tolerate intensive consolidation therapies. Here, we report the development of an AML cell membrane-coated nanoparticle (AMCNP) vaccine platform,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Daniel T., Zhou, Jiarong, Kroll, Ashley V., Fang, Ronnie H., Yan, Ming, Xiao, Crystal, Chen, Xiufen, Kline, Justin, Zhang, Liangfang, Zhang, Dong-Er
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979812/ https://www.ncbi.nlm.nih.gov/pubmed/34845316 http://dx.doi.org/10.1038/s41375-021-01432-w

Ejemplares similares

Cell membrane‐coated nanoparticles for the treatment of cancer
por: Krishnan, Nishta, et al.
Publicado: (2023)

Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
por: Zhuang, Jia, et al.
Publicado: (2020)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
por: Park, Joon Ho, et al.
Publicado: (2021)

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013)

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
por: Fang, Ronnie H., et al.
Publicado: (2014)

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
por: Angsantikul, Pavimol, et al.
Publicado: (2015)

Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2017)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Activation of the STING pathway enhances immunity and improves survival in a murine myeloid leukemia model
por: Curran, Emily, et al.
Publicado: (2014)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Cell membrane coated-nanoparticles for cancer immunotherapy
por: Zeng, Yingping, et al.
Publicado: (2022)

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy
por: Gong, Ping, et al.
Publicado: (2020)

Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis
por: Zhang, Qiangzhe, et al.
Publicado: (2021)

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Bahmani, Baharak, et al.
Publicado: (2021)

Nanoparticle-detained toxins for safe and effective vaccination
por: Hu, Che-Ming J., et al.
Publicado: (2013)

Biomimetic strategies for targeted nanoparticle delivery
por: Dehaini, Diana, et al.
Publicado: (2016)

The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
por: Lin, Chen, et al.
Publicado: (2013)

Membrane-Coated Biomimetic Nanoparticles: A State-of-the-Art Multifunctional Weapon for Tumor Immunotherapy
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Immune evasion in acute myeloid leukemia: current concepts and future directions
por: Teague, Ryan M, et al.
Publicado: (2013)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Nanotechnology for virus treatment
por: Zhou, Jiarong, et al.
Publicado: (2021)

Nanoparticle biointerfacing via platelet membrane cloaking
por: Hu, Che-Ming J., et al.
Publicado: (2015)

Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy
por: Park, Wonchan, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Recent developments in immunotherapy of acute myeloid leukemia
por: Lichtenegger, Felix S., et al.
Publicado: (2017)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
por: Hao, Fang, et al.
Publicado: (2021)

Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
por: Van Acker, Heleen H., et al.
Publicado: (2019)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
por: Khaldoyanidi, Sophia, et al.
Publicado: (2021)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

The potential role of the thymus in immunotherapies for acute myeloid leukemia
por: Hino, Christopher, et al.
Publicado: (2023)

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
por: Chen, Ying, et al.
Publicado: (2023)

Divergent fates of antigen-specific CD8(+) T cell clones in mice with acute leukemia
por: Chen, Xiufen, et al.
Publicado: (2021)

Erythrocyte-Coated Nanoparticles Block Cytotoxic Effects of Group B Streptococcus β-Hemolysin/Cytolysin
por: Koo, Jenny, et al.
Publicado: (2019)

Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer
por: Chen, Qiaoqi, et al.
Publicado: (2021)

PB1795: BIO-INSPIRED NANOMEDICINE FOR TARGETED ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY
por: Wang, X., et al.
Publicado: (2022)

Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia
por: Kadowaki, Norimitsu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ull4nlbhrhlbvtho8ar6kp0ruc